2021 International Congress on Myeloproliferative Neoplasms

 

2021 International Congress on Myeloproliferative Neoplasms
Avatar

Persistent Leukocytosis and PV Progression: Prognostic and Therapeutic Implications

By 2021 International Congress on Myeloproliferative Neoplasms FEATURING John Mascarenhas
By 2021 International Congress on Myeloproliferative Neoplasms FEATURING John Mascarenhas
0 views
December 15, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
Videos
22:32
2021 International Congress on Myeloproliferative Neoplasms

Hereditary Erythrocytosis

Feat. M. McMullin
21:43
2021 International Congress on Myeloproliferative Neoplasms

Clonal and Nonclonal Thrombocytosis

Feat. J. Spivak
21:07
2021 International Congress on Myeloproliferative Neoplasms

Persistent Leukocytosis and PV Progression: Prognostic and Therapeut…

Feat. J. Mascarenhas
22:50
2021 International Congress on Myeloproliferative Neoplasms

JAK2V617F and Clonal Hematopoiesis

Feat. A. Moliterno
21:36
2021 International Congress on Myeloproliferative Neoplasms

MPN Stem Cell Fitness and the Link to Clinical Outcomes

Feat. J. Scandura
23:26
2021 International Congress on Myeloproliferative Neoplasms

Candidate Drugs for Preventing MPN Progression

Feat. R. Hoffman
19:42
2021 International Congress on Myeloproliferative Neoplasms

Hot Topics in Hypereosinophilic Syndrome

Feat. A. Klion
17:39
2021 International Congress on Myeloproliferative Neoplasms

Novel Agents of Potential Value in the MPN

Feat. N. Pemmaraju
15:12
2021 International Congress on Myeloproliferative Neoplasms

A Novel Machine Learning-Derived Dynamic Scoring System Predicts Ris…

Feat. G. Abu-Zeinah
17:41
2021 International Congress on Myeloproliferative Neoplasms

Exploiting Iron Metabolism to Treat Polycythemia Vera

Feat. Y. Ginzburg
24:03
2021 International Congress on Myeloproliferative Neoplasms

Inflammation in MPNs: Clinical and Therapeutic Aspects

Feat. H. Hasselbalch
20:56
2021 International Congress on Myeloproliferative Neoplasms

Treatment Approaches for Early MF

Feat. R. Mesa
32:24
2021 International Congress on Myeloproliferative Neoplasms

New ELN Recommendations for CML

Feat. R. Hehlmann
17:46
2021 International Congress on Myeloproliferative Neoplasms

Which Published Schemas Are Helpful in MPN Transplant Decisions?

Feat. S. Giralt
22:47
2021 International Congress on Myeloproliferative Neoplasms

Anticoagulant Management in the MPNs

Feat. C. Kessler
20:00
2021 International Congress on Myeloproliferative Neoplasms

Are Hematologists Rational?

Feat. R. Gale
12:42
2021 International Congress on Myeloproliferative Neoplasms

Pediatric MPNs: An Unfamiliar Topic

Feat. N. Kucine
20:20
2021 International Congress on Myeloproliferative Neoplasms

Role of NGS in the Diagnosis and Prognosis of MPNs

Feat. A. Vannucchi
21:09
2021 International Congress on Myeloproliferative Neoplasms

Update on the Clinical Status of Commonly Used Drugs in Primary MF

Feat. S. Verstovsek